Endotoxin structure, function, and activity

Endotoxins: Pyrogens, LAL Testing and Depyrogenation, Third Edition

Volumn , Issue , 2007, Pages 67-90

  Williams, Kevin L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84973448036     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (77)

1. Beveridge TJ. Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 1999; 181(16):4725-4733.
2. Raetz C et al. Gram negative endotoxin: an extraordinary lipid with profound effects on eukaryotic signal transduction. FASEB 1991; 5(12):2652-2660.
3. Raetz C. Biochemistry of endotoxins. Annu Rev Biochem 1990; 59:129-170.
4. Galanos C, Luderitz O. Lipopolysaccharide: properties of an amphipathic molecule. In: Rietschel ET, ed. Handbook of Endotoxin, Chemistry of Endotoxin. Vol. 1. Elsevier Science Publishers, 1984.
5. Rietschel, Brade. Bacterial endotoxins. Sci Am 1992; Aug:54-61.
6. Hurley J. Endotoxemia: methods of detection and clinical correlates. Clin Micro Rev 1995; April:268-292.
7. Barnickel G, Bradaczek H, Naumann D, Rietschel ET, Giesbrecnt P, Labischinski IH. High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol 1985; 162(1):9-20.
8. Hitchcock PJ et al. Lipopolysaccharide nomenclature-past, present, and future. J Bacteriol 1986; 166:699-701.
9. Mangan DF et al. Stimulation of human monocdytes by endotoxin-associated protein: inhibition of programmed cell death (apoptosis) and potential significance in adjuvanticity. Infect Immun 1992; 60:1684-1686.
10. Kabir ST, et al. Bacterial toxins and cell membranes. In: Jeljaszewicz T, Wadstrom, eds. New York: Academic Press New York, 1978.
11. Henderson B, Wilson M. Cytokine induction by bacteria: beyond lipopolysaccharide. Cytokine 1996; 8(4):269-282.
12. Kelly MT, Brenner DJ, JJ Farmer III. Enterobacteriaceae. In: Lennette EH, ed. Manual of Clinical Microbiology. Washington: American Society for Microbiology, 1985:263-277.
13. Dundas S, Todd WTA. Escherichia coli O157 and human disease. Curr Opin Infect Dis 1998; 11:171-175.
14. Rietschel et al. Bacterial endotoxins: molecular relationship of structure to activity and function. FASEB 1994; 18:217-225.
15. Nnalue AN. All accessible epitopes in the Salmonella lipopolysaccharide core are associated with branch residues. Infect Immun 1999; 67(2):998-1003.
16. Luderitz OH. Endotoxins and other cell wall components of gram negative bacteria and their biological activities, p. 234-246. In: Schiessinger D (ed)., Microbiology-1977, American Society Microbiology, Washington, D.C. Annu Rev Microbiol 1977; 239-246.
17. Nowotny A. Relation of structure to function in bacterial endotoxin. Annu Rev Microbiol 1977:247-252.
18. Rietschel et al. Chemical structure of lipid A. Microbiology 1977; 262.
19. Galanos C et al. Synthetic and Natural E. coli free lipid A express identical endotoxic activities. Eur J Biochem 1985; 148:1-5.
20. Rietschel, E. Th., et al., Bacterial endotoxin: molecular releationships of structure to activity and function, FASEB J. 1994; 8:217-225.
21. Schnaitman CA, Klena JD. Genetics of lipopolysaccharide biosynthesis in enteric bacteria. Microbiol Rev 1993 September; 57:655-682.
22. Kastowsky et al. Molecular modeling of the three-dimensional structure and conformational flexibility of bacterial lipopolysaccharide. J Bacteriol 1992; July: 4798-4806.
23. Morrison DC et al. Structure-function relationships of bacterial endotoxins, contribution to microbial sepsis. In: Opal SM, Cross AS, eds. Infect Dis Clin North Am, Philadelphia: Harcourt Brace & Co 1999; 13(2):313-340.
24. Sweadner et al. Filtration removal of endotoxin (pyrogens) in solution in different states of aggregation. Appl Environ Micro 1977; 34(4):382-285.
25. Pedron T et al. New synthetic analogs of Lipid A as lipopolysaccharide agonists or antagonists of B lymphocyte activation. Int Immunol 1992; 4(4):533-540.
26. Loppnow H et al. IL-1 Induction-capacity of defined lipopolysaccharide partical structures. J Immunol 1989; 142(9):3229-3238.
27. Nowotny A. Review of the molecular requirements of endotoxic actions. Rev Infect Dis 1987; 9(suppl 5):S503-S511.
28. Lynn WA, Golenbock DT. Lipopolysaccharide antagonists. Immunol Today 1992.
29. Johnson AG et al. Characterization of a nontoxic monophosphoryl lipid A. Rev Infect Dis 1987; 9(suppl 5):S512-S516.
30. Morrison D, Ulevitch R. The effects of bacterial endotoxins on host mediation systems. Am J Pathol 1978; 93(527).
31. Galanos C et al. Immunogenic properties of lipid A. Rev Infect Dis 1984; 6:546-552.
32. Brade L et al. The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun 1987; 55:2636.
33. Galanos C et al. Biological activities of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun 1972; 31:230.
34. Rietschel E et al. Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun 1973; 8:173.
35. Novitsky TJ. Factors affecting the recovery of endotoxin. 1992; 10(1):1-2.
36. Morrison DC et al. Structural requirements for gelation of the Limulus amoebocyte lysate by endotoxin. Prog Clin Biol Res 1987; 231:55-73.
37. Mattsby-Baltzer et al. Endotoxin shedding by enterobacteria free and cell-bound endotoxin differ in Limulus activity. Prog clin Biol Res 1991; 59:689-695.
38. Luderitz O, Galanos C. Lipid A: chemical structure and biological activity. J Infect Dis 1973; 128(17).
39. Jiao B, Freudenberg M, Galanos C. Characterization of the lipid A component of genuine smooth-form lipopolysaccharide. Eur J Biochem 1989; 180:515-518.
40. Henderson BS, Poole S, Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis. Microbiol Rev 1996; 60:316-341.
41. Reitschel ET, Wahl. In: Rietschel, ed. Handbook of Endotoxin. Elsevier Science Publishers, 1984.
42. Katz et al. Potent CD14-mediated signalling of human leukocytes by E. coli can be mediated by interaction of whole bacteria and host cells without excessive prior release of endotoxin. Infect Immun 1996; 64:3592.
43. Cadieux JE et al. Spontaneous release of lipopolysaccharide by Pseudomonas aeruginosa. J Bacteriol 1983; 155:817-825.
44. Johnson KG et al. Cellular and free lipopolysaccharides of some species of Neisseria. Can J Microbiol 1975; 21:1969-1980.
45. Hurley JC, Tosolini FA. A Quantitative micro-assay for endotoxin and correlation with bacterial density in urine. J Microbiol Methods 1992; 15:91-99.
46. van Deuren M, Brandtzaeg P, Meer JWMVD. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000; 13:144-166.
47. Li Z, Clarke A, Beveridge T. Gram-negative bacteria produce membrane vesicles which are capable of killing other bacteria. J Bacteriol 1998; 180(20):5478-5483.
48. Shnyra A et al. Role of the physical state of Salmonella lipopolysaccharide in expression of biological and endotoxin properties. Infect Immun 1993; 61(12):5351-5360.
49. Tesh TL, Morrison DC. The interaction of E. coli with normal human serum: factors affecting the capacity of serum to mediate lipopolysacharide release. Microb Pathog 1988; 4(175).
50. Tesh TL, Morrison DC. The physical chemical characterization and biological activity of serum-released lipopolysacharides. J Immunol 1988; 141:3523.
51. Kitchens RL et al. Plasma lipoproteins promote the release of bacterial lipopolysaccharide from the monocyte cell surface. J Biol Chem 1999; 274(48):34116-34122.
52. Shands JW. Affinity of endotoxin for membranes. J Infect Dis 1973; 128(suppl):197-201.
53. Shands JW. Morphological structures of isolated bacterial lipopolysaccharide. J Mol Biol 1967; 25:15-21.
54. Brandenburg K, Rietschel ET, Brade H. Conformation of lipid A-the endotoxic center of bacterial lipopolysaccharide. J Endotoxin Res 1996; 313:173-178.
55. Tanford C. The hydrophobic effect: formation of micelles and biological membranes. 2nd ed. New York: John Wiley & Sons, 1980.
56. Sikkema J, De Bont JAM, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev 1995; 59(2):201-222.
57. Shands JW, Chun PW. The dispersion of gram-negative lipopolysaccharide by deoxycholate. J Biol Chem 1980; 255(3):1221-1226.
58. Luhm J et al. Hypothermia enhances the biological activity of lipopolysaccharide by altering its fluidity state. Eur J Biochem 1988; 256:325-333.
59. Falk MC et al. Aggregation of serum proteins with lipopolysaccharide (LPS): characterization of the precipitable LPS-protein complex. J Endotoxin Res 1996; 3(2):129-142.
60. Din ZZ et al. Effect of pH on solubility and ionic state of lipopolysaccharide obtained from the deep rough mutant of Escherichia coli. Biochemistry 32:4579-4586.
61. Takayama et al. Physiochemical properties of the lipopolysaccharide unit that activates B lymphocytes. J Biol Chem 1990; 265(23):14023-14029.
62. Mueller M, Linder B, Kusumoto S, Fukase K, Andra B Schromm, Ulrich Seydel. Aggregates are the biologically active units of endotoxin. J Biol Chem 2004; 279(25):26307-26313.
63. Brandenburg KJ, Rietschel ET, Mayer H, Koch MH, Weckesser J, Seydel U. Influence of the supramolecular structure of free lipid A on its biological activities. FEBS J Eur Biochem 1993; 218:555-563.
64. Kato H et al. Chemical structure of lipid A isolated from Flavobacterium meningosepticum lipopolysaccharide. J Bacteriol 1998; 180(15):3891-3899.
65. Seydel U et al. The generalized endotoxic principle. Eur J Immunol 2003; 33:1586-1592.
66. Schromm AB, Brandenburg K, Loppnow H, et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem FEBS 2000; 267:2008-2013.
67. Wachtel RE, Tsuji K. Comparison of Limulus amebocyte lysates and correlation with the United States Pharmacopeial pyrogen test. Appl Environ Microbiol 1977; 33:1265-1269.
68. Sveen K, Hofstad T, Milner KC. Lethality for mice and chick embryos, pyrogenicity in rabbits and ability to gelate lysate from amoebocytes of Limulus polyphemus by lipopolysaccharides from Bacteroides, Fusobacterium and Veillonella. Acta Pathol Microbiol Scand B 1977; 85:388-396.
69. Wong KH, Moss CW, Hochstein DH, Arko RJ, Schalla WO. Endotoxicity of the Legionnaire’s disease bacterium. Ann Intern Med 1979; 90:624-627.
70. Weary ME, Pearson FC, Bohon J, Donohue G. The activity of various endotoxins in the USP rabbit test and in three different LAL tests. Prog Clin Biol Res 1982; 93:365-379.
71. Devleeschouwer MJ, Cornil MF, Dony J. Studies on the sensitivity and specificity of the Limulus amebocyte lysate test and rabbit pyrogen assays. Appl Environ Microbiol 1985; 50:1509-1511.
72. Luderitz O, Staub A, Westphal O. Immunochemistry of O and R antigens of Salmonella and related enterobacteriaceae. Bacteriol Rev 1966; 30(192).
73. Bradley S. Cellular and molecular mechanisms of bacterial endotoxins. Annu Rev Microbiol 1979; 33(67).
74. Galanos C et al. Chemical, physical, and biological properties of bacterial lipopolysaccharides. In: Cohen E, ed. Biomedical Applications of the Horseshoe Crab (Limulidae). New York: Alan R. Liss, 1979:319.
75. Komuro T, Murai T, Kawasaki H. Effect of sonication on the dispersion state of lipopolysaccharide and its pyrogenicity in rabbits. Chem Pharm Bull 1987; 35(12):4946-4952.
76. Kotra LP et al. Visualizing bacteria at high resolution. ASM News 2000; 66(1):675-681.
77. Seydel U, Oikawa M, Fukase K, Kusumoto S, Brandenburg K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur J Biochem 2000; 267:3032-3039.